{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:02:35Z","timestamp":1790823755477,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T00:00:00Z","timestamp":1302480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1743-422x-8-161","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T06:21:29Z","timestamp":1302589289000},"source":"Crossref","is-referenced-by-count":139,"title":["An overview of HCV molecular biology, replication and immune responses"],"prefix":"10.1186","volume":"8","author":[{"given":"Usman A","family":"Ashfaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Riazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"1276_CR1","first-page":"4","volume":"41","author":"N S Raja","year":"2008","unstructured":"Raja N S, Janjua K A: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. J Microbiol Immunol Infect 2008, 41: 4-8.","journal-title":"J Microbiol Immunol Infect"},{"key":"1276_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0168-8278(01)00179-9","volume":"35","author":"M Berenguer","year":"2001","unstructured":"Berenguer M, Lopez-Labrador FX, Wright TL: Hepatitis C and liver transplantation. J Hepatol 2001, 35: 666-678. 10.1016\/S0168-8278(01)00179-9","journal-title":"J Hepatol"},{"key":"1276_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00028-7","volume":"58","author":"R De Francesco","year":"2003","unstructured":"De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G: Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res 2003, 58: 1-16. 10.1016\/S0166-3542(03)00028-7","journal-title":"Antiviral Res"},{"key":"1276_CR4","first-page":"838","volume":"5","author":"PL Beaulieu","year":"2004","unstructured":"Beaulieu PL, Tsantrizos YS: Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Curr Opin Investig Drugs 2004, 5: 838-850.","journal-title":"Curr Opin Investig Drugs"},{"key":"1276_CR5","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1073\/pnas.91.17.8239","volume":"91","author":"J Bukh","year":"1994","unstructured":"Bukh J, Purcell RH, Miller RH: Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 1994, 91: 8239-8243. 10.1073\/pnas.91.17.8239","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR6","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1128\/JVI.68.6.3631-3641.1994","volume":"68","author":"E Santolini","year":"1994","unstructured":"Santolini E, Migliaccio G, La Monica N: Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994, 68: 3631-3641.","journal-title":"J Virol"},{"key":"1276_CR7","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1074\/jbc.M108798200","volume":"277","author":"RG Hope","year":"2002","unstructured":"Hope RG, Murphy DJ, McLauchlan J: The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem 2002, 277: 4261-4270. 10.1074\/jbc.M108798200","journal-title":"J Biol Chem"},{"key":"1276_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/gast.2002.31001","volume":"122","author":"H Lerat","year":"2002","unstructured":"Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM: Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002, 122: 352-365. 10.1053\/gast.2002.31001","journal-title":"Gastroenterology"},{"key":"1276_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1369-5274(02)00341-7","volume":"5","author":"TL Tellinghuisen","year":"2002","unstructured":"Tellinghuisen TL, Rice CM: Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 2002, 5: 419-427. 10.1016\/S1369-5274(02)00341-7","journal-title":"Curr Opin Microbiol"},{"key":"1276_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","volume":"546","author":"HE Drummer","year":"2003","unstructured":"Drummer HE, Maerz A, Poumbourios P: Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 2003, 546: 385-390. 10.1016\/S0014-5793(03)00635-5","journal-title":"FEBS Lett"},{"key":"1276_CR11","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","volume":"79","author":"A Goffard","year":"2005","unstructured":"Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J: Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 2005, 79: 8400-8409. 10.1128\/JVI.79.13.8400-8409.2005","journal-title":"J Virol"},{"key":"1276_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2003.10.008","volume":"319","author":"T Slater-Handshy","year":"2004","unstructured":"Slater-Handshy T, Droll DA, Fan X, Di Bisceglie AM, Chambers TJ: HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Virology 2004, 319: 36-48. 10.1016\/j.virol.2003.10.008","journal-title":"Virology"},{"key":"1276_CR13","doi-asserted-by":"publisher","first-page":"14199","DOI":"10.1073\/pnas.2335981100","volume":"100","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, Emerson SU, Cosset FL, Purcell RH: In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA 2003, 100: 14199-14204. 10.1073\/pnas.2335981100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR14","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0832180100","volume":"100","author":"M Hsu","year":"2003","unstructured":"Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA: Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003, 100: 7271-7276. 10.1073\/pnas.0832180100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR15","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","volume":"21","author":"E Scarselli","year":"2002","unstructured":"Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A: The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. Embo J 2002, 21: 5017-5025. 10.1093\/emboj\/cdf529","journal-title":"Embo J"},{"key":"1276_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S: Binding of hepatitis C virus to CD81. Science 1998, 282: 938-941. 10.1126\/science.282.5390.938","journal-title":"Science"},{"key":"1276_CR17","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","volume":"96","author":"V Agnello","year":"1999","unstructured":"Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX: Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999, 96: 12766-12771. 10.1073\/pnas.96.22.12766","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR18","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1073\/pnas.0831128100","volume":"100","author":"JP Gardner","year":"2003","unstructured":"Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC: L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA 2003, 100: 4498-4503. 10.1073\/pnas.0831128100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jmv.10192","volume":"68","author":"A Boulestin","year":"2002","unstructured":"Boulestin A, Sandres-Saune K, Payen JL, Alric L, Dubois M, Pasquier C, Vinel JP, Pascal JP, Puel J, Izopet J: Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha. J Med Virol 2002, 68: 221-228. 10.1002\/jmv.10192","journal-title":"J Med Virol"},{"key":"1276_CR20","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1128\/JVI.72.5.4288-4296.1998","volume":"72","author":"SJ Polyak","year":"1998","unstructured":"Polyak SJ, McArdle S, Liu SL, Sullivan DG, Chung M, Hofgartner WT, Carithers RL Jr, McMahon BJ, Mullins JI, Corey L, Gretch DR: Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 1998, 72: 4288-4296.","journal-title":"J Virol"},{"issue":"Pt 7","key":"1276_CR21","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1099\/0022-1317-76-7-1871","volume":"76","author":"LJ van Doorn","year":"1995","unstructured":"van Doorn LJ, Kleter GE, Stuyver L, Maertens G, Brouwer JT, Schalm SW, Heijtink RA, Quint WG: Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries. J Gen Virol 1995,76(Pt 7):1871-1876. 10.1099\/0022-1317-76-7-1871","journal-title":"J Gen Virol"},{"key":"1276_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0014-5793(02)03851-6","volume":"535","author":"SD Griffin","year":"2003","unstructured":"Griffin SD, Beales LP, Clarke DS, Worsfold O, Evans SD, Jaeger J, Harris MP, Rowlands DJ: The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 2003, 535: 34-38. 10.1016\/S0014-5793(02)03851-6","journal-title":"FEBS Lett"},{"key":"1276_CR23","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1371\/journal.ppat.0030103","volume":"3","author":"E Steinmann","year":"2007","unstructured":"Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T: Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog 2007, 3: e103. 10.1371\/journal.ppat.0030103","journal-title":"PLoS Pathog"},{"key":"1276_CR24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.71.2.1497-1505.1997","volume":"71","author":"AA Khromykh","year":"1997","unstructured":"Khromykh AA, Westaway EG: Subgenomic replicons of the flavivirus Kunjin: construction and applications. J Virol 1997, 71: 1497-1505.","journal-title":"J Virol"},{"key":"1276_CR25","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"T Pietschmann","year":"2006","unstructured":"Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R: Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006, 103: 7408-7413. 10.1073\/pnas.0504877103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR26","doi-asserted-by":"publisher","first-page":"10583","DOI":"10.1073\/pnas.90.22.10583","volume":"90","author":"A Grakoui","year":"1993","unstructured":"Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM: A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci USA 1993, 90: 10583-10587. 10.1073\/pnas.90.22.10583","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR27","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/JVI.69.7.4127-4136.1995","volume":"69","author":"KE Reed","year":"1995","unstructured":"Reed KE, Grakoui A, Rice CM: Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. J Virol 1995, 69: 4127-4136.","journal-title":"J Virol"},{"key":"1276_CR28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nature04975","volume":"442","author":"IC Lorenz","year":"2006","unstructured":"Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM: Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 2006, 442: 831-835. 10.1038\/nature04975","journal-title":"Nature"},{"key":"1276_CR29","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1128\/JVI.72.8.6758-6769.1998","volume":"72","author":"P Gallinari","year":"1998","unstructured":"Gallinari P, Brennan D, Nardi C, Brunetti M, Tomei L, Steinkuhler C, De Francesco R: Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol 1998, 72: 6758-6769.","journal-title":"J Virol"},{"key":"1276_CR30","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1128\/JVI.74.5.2293-2304.2000","volume":"74","author":"B Wolk","year":"2000","unstructured":"Wolk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE, Moradpour D: Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 2000, 74: 2293-2304. 10.1128\/JVI.74.5.2293-2304.2000","journal-title":"J Virol"},{"key":"1276_CR31","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/JVI.67.7.3835-3844.1993","volume":"67","author":"R Bartenschlager","year":"1993","unstructured":"Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3\/4 and NS4\/5 junctions. J Virol 1993, 67: 3835-3844.","journal-title":"J Virol"},{"key":"1276_CR32","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1128\/JVI.68.8.5045-5055.1994","volume":"68","author":"R Bartenschlager","year":"1994","unstructured":"Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 1994, 68: 5045-5055.","journal-title":"J Virol"},{"key":"1276_CR33","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.67.5.2832-2843.1993","volume":"67","author":"A Grakoui","year":"1993","unstructured":"Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM: Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 1993, 67: 2832-2843.","journal-title":"J Virol"},{"key":"1276_CR34","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JVI.71.4.2838-2843.1997","volume":"71","author":"P Borowski","year":"1997","unstructured":"Borowski P, Oehlmann K, Heiland M, Laufs R: Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase. J Virol 1997, 71: 2838-2843.","journal-title":"J Virol"},{"key":"1276_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nature04078","volume":"436","author":"M Gale Jr","year":"2005","unstructured":"Gale M Jr, Foy EM: Evasion of intracellular host defence by hepatitis C virus. Nature 2005, 436: 939-945. 10.1038\/nature04078","journal-title":"Nature"},{"key":"1276_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature02704","volume":"430","author":"V Serebrov","year":"2004","unstructured":"Serebrov V, Pyle AM: Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase. Nature 2004, 430: 476-480. 10.1038\/nature02704","journal-title":"Nature"},{"key":"1276_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nsmb920","volume":"12","author":"MK Levin","year":"2005","unstructured":"Levin MK, Gurjar M, Patel SS: A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase. Nat Struct Mol Biol 2005, 12: 429-435. 10.1038\/nsmb920","journal-title":"Nat Struct Mol Biol"},{"key":"1276_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0092-8674(00)81351-3","volume":"87","author":"JL Kim","year":"1996","unstructured":"Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, et al.: Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996, 87: 343-355. 10.1016\/S0092-8674(00)81351-3","journal-title":"Cell"},{"key":"1276_CR39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/JVI.71.1.790-796.1997","volume":"71","author":"SI Asabe","year":"1997","unstructured":"Asabe SI, Tanji Y, Satoh S, Kaneko T, Kimura K, Shimotohno K: The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. J Virol 1997, 71: 790-796.","journal-title":"J Virol"},{"key":"1276_CR40","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1099\/vir.0.82211-0","volume":"87","author":"M Lundin","year":"2006","unstructured":"Lundin M, Lindstrom H, Gronwall C, Persson MA: Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein. J Gen Virol 2006, 87: 3263-3272. 10.1099\/vir.0.82211-0","journal-title":"J Gen Virol"},{"key":"1276_CR41","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1128\/JVI.71.9.6465-6471.1997","volume":"71","author":"C Lin","year":"1997","unstructured":"Lin C, Wu JW, Hsiao K, Su MS: The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. J Virol 1997, 71: 6465-6471.","journal-title":"J Virol"},{"key":"1276_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/viro.2001.0873","volume":"284","author":"T Hugle","year":"2001","unstructured":"Hugle T, Fehrmann F, Bieck E, Kohara M, Krausslich HG, Rice CM, Blum HE, Moradpour D: The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 2001, 284: 70-81. 10.1006\/viro.2001.0873","journal-title":"Virology"},{"key":"1276_CR43","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1128\/JVI.76.12.5974-5984.2002","volume":"76","author":"D Egger","year":"2002","unstructured":"Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K: Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002, 76: 5974-5984. 10.1128\/JVI.76.12.5974-5984.2002","journal-title":"J Virol"},{"key":"1276_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1099\/vir.0.80768-0","volume":"86","author":"SN Gretton","year":"2005","unstructured":"Gretton SN, Taylor AI, McLauchlan J: Mobility of the hepatitis C virus NS4B protein on the endoplasmic reticulum membrane and membrane-associated foci. J Gen Virol 2005, 86: 1415-1421. 10.1099\/vir.0.80768-0","journal-title":"J Gen Virol"},{"key":"1276_CR45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/emm.2006.29","volume":"38","author":"AG Wang","year":"2006","unstructured":"Wang AG, Moon HB, Kim JM, Hwang SB, Yu DY, Lee DS: Expression of hepatitis C virus nonstructural 4B in transgenic mice. Exp Mol Med 2006, 38: 241-246.","journal-title":"Exp Mol Med"},{"key":"1276_CR46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/vir.0.19691-0","volume":"85","author":"A Macdonald","year":"2004","unstructured":"Macdonald A, Crowder K, Street A, McCormick C, Harris M: The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 2004, 85: 721-729. 10.1099\/vir.0.19691-0","journal-title":"J Gen Virol"},{"key":"1276_CR47","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1128\/JVI.71.10.7187-7197.1997","volume":"71","author":"KE Reed","year":"1997","unstructured":"Reed KE, Xu J, Rice CM: Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J Virol 1997, 71: 7187-7197.","journal-title":"J Virol"},{"key":"1276_CR48","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.1074\/jbc.M111289200","volume":"277","author":"V Brass","year":"2002","unstructured":"Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, Blum HE, Penin F, Moradpour D: An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 2002, 277: 8130-8139. 10.1074\/jbc.M111289200","journal-title":"J Biol Chem"},{"key":"1276_CR49","doi-asserted-by":"publisher","first-page":"40835","DOI":"10.1074\/jbc.M404761200","volume":"279","author":"F Penin","year":"2004","unstructured":"Penin F, Brass V, Appel N, Ramboarina S, Montserret R, Ficheux D, Blum HE, Bartenschlager R, Moradpour D: Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. J Biol Chem 2004, 279: 40835-40843. 10.1074\/jbc.M404761200","journal-title":"J Biol Chem"},{"key":"1276_CR50","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1128\/JVI.73.12.9984-9991.1999","volume":"73","author":"P Neddermann","year":"1999","unstructured":"Neddermann P, Clementi A, De Francesco R: Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J Virol 1999, 73: 9984-9991.","journal-title":"J Virol"},{"key":"1276_CR51","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1128\/JVI.77.10.6055-6061.2003","volume":"77","author":"M Elazar","year":"2003","unstructured":"Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, Glenn JS: Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol 2003, 77: 6055-6061. 10.1128\/JVI.77.10.6055-6061.2003","journal-title":"J Virol"},{"key":"1276_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285: 110-113. 10.1126\/science.285.5424.110","journal-title":"Science"},{"key":"1276_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/viro.2001.1225","volume":"292","author":"ST Shi","year":"2002","unstructured":"Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM: Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 2002, 292: 198-210. 10.1006\/viro.2001.1225","journal-title":"Virology"},{"key":"1276_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/hep.20851","volume":"42","author":"D Moradpour","year":"2005","unstructured":"Moradpour D, Brass V, Penin F: Function follows form: the structure of the N-terminal domain of HCV NS5A. Hepatology 2005, 42: 732-735. 10.1002\/hep.20851","journal-title":"Hepatology"},{"key":"1276_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.2001.0885","volume":"284","author":"SL Tan","year":"2001","unstructured":"Tan SL, Katze MG: How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 2001, 284: 1-12. 10.1006\/viro.2001.0885","journal-title":"Virology"},{"key":"1276_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/viro.1997.8493","volume":"230","author":"MJ Gale Jr","year":"1997","unstructured":"Gale MJ Jr, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG: Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997, 230: 217-227. 10.1006\/viro.1997.8493","journal-title":"Virology"},{"key":"1276_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI118025","volume":"96","author":"N Enomoto","year":"1995","unstructured":"Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C: Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995, 96: 224-230. 10.1172\/JCI118025","journal-title":"J Clin Invest"},{"key":"1276_CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1460-2075.1996.tb00329.x","volume":"15","author":"SE Behrens","year":"1996","unstructured":"Behrens SE, Tomei L, De Francesco R: Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. Embo J 1996, 15: 12-22.","journal-title":"Embo J"},{"key":"1276_CR59","doi-asserted-by":"publisher","first-page":"15479","DOI":"10.1074\/jbc.273.25.15479","volume":"273","author":"T Yamashita","year":"1998","unstructured":"Yamashita T, Kaneko S, Shirota Y, Qin W, Nomura T, Kobayashi K, Murakami S: RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J Biol Chem 1998, 273: 15479-15486. 10.1074\/jbc.273.25.15479","journal-title":"J Biol Chem"},{"key":"1276_CR60","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/13305","volume":"6","author":"CA Lesburg","year":"1999","unstructured":"Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC: Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 1999, 6: 937-943. 10.1038\/13305","journal-title":"Nat Struct Biol"},{"key":"1276_CR61","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nature04080","volume":"436","author":"R De Francesco","year":"2005","unstructured":"De Francesco R, Migliaccio G: Challenges and successes in developing new therapies for hepatitis C. Nature 2005, 436: 953-960. 10.1038\/nature04080","journal-title":"Nature"},{"key":"1276_CR62","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/JVI.73.4.3317-3325.1999","volume":"73","author":"ME Major","year":"1999","unstructured":"Major ME, Mihalik K, Fernandez J, Seidman J, Kleiner D, Kolykhalov AA, Rice CM, Feinstone SM: Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 1999, 73: 3317-3325.","journal-title":"J Virol"},{"key":"1276_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.282.5386.103","volume":"282","author":"AU Neumann","year":"1998","unstructured":"Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998, 282: 103-107. 10.1126\/science.282.5386.103","journal-title":"Science"},{"key":"1276_CR64","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/hep.1840210243","volume":"21","author":"P Simmonds","year":"1995","unstructured":"Simmonds P: Variability of hepatitis C virus. Hepatology 1995, 21: 570-583. 10.1002\/hep.1840210243","journal-title":"Hepatology"},{"key":"1276_CR65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0168-8278(96)80135-8","volume":"24","author":"P Simmonds","year":"1996","unstructured":"Simmonds P, Mellor J, Craxi A, Sanchez-Tapias JM, Alberti A, Prieto J, Colombo M, Rumi MG, Lo Iacano O, Ampurdanes-Mingall S, et al.: Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 1996, 24: 517-524. 10.1016\/S0168-8278(96)80135-8","journal-title":"J Hepatol"},{"key":"1276_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-2007-1007262","volume":"15","author":"J Bukh","year":"1995","unstructured":"Bukh J, Miller RH, Purcell RH: Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995, 15: 41-63. 10.1055\/s-2007-1007262","journal-title":"Semin Liver Dis"},{"issue":"Pt 11","key":"1276_CR67","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","volume":"74","author":"P Simmonds","year":"1993","unstructured":"Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993,74(Pt 11):2391-2399. 10.1099\/0022-1317-74-11-2391","journal-title":"J Gen Virol"},{"key":"1276_CR68","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1002\/hep.1840360712","volume":"36","author":"MJ Alter","year":"2002","unstructured":"Alter MJ: Prevention of spread of hepatitis C. Hepatology 2002, 36: S93-98. 10.1002\/hep.1840360712","journal-title":"Hepatology"},{"key":"1276_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2334-8-69","volume":"8","author":"M Idrees","year":"2008","unstructured":"Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8: 69. 10.1186\/1471-2334-8-69","journal-title":"BMC Infect Dis"},{"key":"1276_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2893.1999.6120139.x","volume":"6","author":"WHO","year":"1999","unstructured":"WHO: Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999, 6: 35-47. 10.1046\/j.1365-2893.1999.6120139.x","journal-title":"J Viral Hepat"},{"key":"1276_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00018-007-7291-8","volume":"65","author":"F Helle","year":"2008","unstructured":"Helle F, Dubuisson J: Hepatitis C virus entry into host cells. Cell Mol Life Sci 2008, 65: 100-112. 10.1007\/s00018-007-7291-8","journal-title":"Cell Mol Life Sci"},{"key":"1276_CR72","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/hep.21321","volume":"44","author":"H Barth","year":"2006","unstructured":"Barth H, Liang TJ, Baumert TF: Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 2006, 44: 527-535. 10.1002\/hep.21321","journal-title":"Hepatology"},{"key":"1276_CR73","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.molcel.2004.12.001","volume":"16","author":"SP Goff","year":"2004","unstructured":"Goff SP: Retrovirus restriction factors. Mol Cell 2004, 16: 849-859. 10.1016\/j.molcel.2004.12.001","journal-title":"Mol Cell"},{"key":"1276_CR74","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/JVI.01519-06","volume":"81","author":"J Luban","year":"2007","unstructured":"Luban J: Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol 2007, 81: 1054-1061. 10.1128\/JVI.01519-06","journal-title":"J Virol"},{"key":"1276_CR75","doi-asserted-by":"publisher","first-page":"e1866","DOI":"10.1371\/journal.pone.0001866","volume":"3","author":"V Rocha-Perugini","year":"2008","unstructured":"Rocha-Perugini V, Montpellier C, Delgrange D, Wychowski C, Helle F, Pillez A, Drobecq H, Le Naour F, Charrin S, Levy S, et al.: The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS One 2008, 3: e1866. 10.1371\/journal.pone.0001866","journal-title":"PLoS One"},{"key":"1276_CR76","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1099\/vir.0.19305-0","volume":"84","author":"N El-Hage","year":"2003","unstructured":"El-Hage N, Luo G: Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol 2003, 84: 2761-2769. 10.1099\/vir.0.19305-0","journal-title":"J Gen Virol"},{"key":"1276_CR77","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1128\/JVI.77.9.5487-5492.2003","volume":"77","author":"R Gosert","year":"2003","unstructured":"Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, Bienz K, Moradpour D: Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 2003, 77: 5487-5492. 10.1128\/JVI.77.9.5487-5492.2003","journal-title":"J Virol"},{"key":"1276_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","volume":"125","author":"JT Gerlach","year":"2003","unstructured":"Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR: Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003, 125: 80-88. 10.1016\/S0016-5085(03)00668-1","journal-title":"Gastroenterology"},{"key":"1276_CR79","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1056\/NEJMoa011232","volume":"345","author":"E Jaeckel","year":"2001","unstructured":"Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP: Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001, 345: 1452-1457. 10.1056\/NEJMoa011232","journal-title":"N Engl J Med"},{"key":"1276_CR80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jcv.2004.08.004","volume":"32","author":"WP Hofmann","year":"2005","unstructured":"Hofmann WP, Zeuzem S, Sarrazin C: Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. J Clin Virol 2005, 32: 86-91. 10.1016\/j.jcv.2004.08.004","journal-title":"J Clin Virol"},{"key":"1276_CR81","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/S1051-0443(07)61783-7","volume":"13","author":"AM Di Bisceglie","year":"2002","unstructured":"Di Bisceglie AM: Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 2002, 13: S169-171. 10.1016\/S1051-0443(07)61783-7","journal-title":"J Vasc Interv Radiol"},{"key":"1276_CR82","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Hoofnagle JH: Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005, 436: 967-972. 10.1038\/nature04082","journal-title":"Nature"},{"key":"1276_CR83","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","volume":"352","author":"T Poynard","year":"1998","unstructured":"Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J: Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998, 352: 1426-1432. 10.1016\/S0140-6736(98)07124-4","journal-title":"Lancet"},{"key":"1276_CR84","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2893.2007.00887.x","volume":"15","author":"M Deutsch","year":"2008","unstructured":"Deutsch M, Hadziyannis SJ: Old and emerging therapies in chronic hepatitis C: an update. J Viral Hepat 2008, 15: 2-11.","journal-title":"J Viral Hepat"},{"key":"1276_CR85","first-page":"68","volume":"24","author":"RK Dhiman","year":"2005","unstructured":"Dhiman RK, Chawla Y: Acute viral hepatitis C should be treated. Indian J Gastroenterol 2005, 24: 68-71.","journal-title":"Indian J Gastroenterol"},{"key":"1276_CR86","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jhep.2006.01.037","volume":"45","author":"D Di Bona","year":"2006","unstructured":"Di Bona D, Cippitelli M, Fionda C, Camma C, Licata A, Santoni A, Craxi A: Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol 2006, 45: 271-279. 10.1016\/j.jhep.2006.01.037","journal-title":"J Hepatol"},{"key":"1276_CR87","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/hep.20139","volume":"39","author":"B Gao","year":"2004","unstructured":"Gao B, Hong F, Radaeva S: Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology 2004, 39: 880-890. 10.1002\/hep.20139","journal-title":"Hepatology"},{"key":"1276_CR88","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1086\/339485","volume":"185","author":"DA Schiappa","year":"2002","unstructured":"Schiappa DA, Mittal C, Brown JA, Mika BP: Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness. J Infect Dis 2002, 185: 868-877. 10.1086\/339485","journal-title":"J Infect Dis"},{"key":"1276_CR89","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.1128\/JVI.00459-06","volume":"80","author":"W Lin","year":"2006","unstructured":"Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, Holtzman MJ, Chung RT: Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 2006, 80: 9226-9235. 10.1128\/JVI.00459-06","journal-title":"J Virol"},{"key":"1276_CR90","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1021\/jm0401255","volume":"47","author":"A Gopalsamy","year":"2004","unstructured":"Gopalsamy A, Lim K, Ciszewski G, Park K, Ellingboe JW, Bloom J, Insaf S, Upeslacis J, Mansour TS, Krishnamurthy G, et al.: Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors. J Med Chem 2004, 47: 6603-6608. 10.1021\/jm0401255","journal-title":"J Med Chem"},{"key":"1276_CR91","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413: 732-738. 10.1038\/35099560","journal-title":"Nature"},{"key":"1276_CR92","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U Muller","year":"1994","unstructured":"Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M: Functional role of type I and type II interferons in antiviral defense. Science 1994, 264: 1918-1921. 10.1126\/science.8009221","journal-title":"Science"},{"key":"1276_CR93","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","volume":"75","author":"CB Bigger","year":"2001","unstructured":"Bigger CB, Brasky KM, Lanford RE: DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001, 75: 7059-7066. 10.1128\/JVI.75.15.7059-7066.2001","journal-title":"J Virol"},{"key":"1276_CR94","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1128\/JVI.77.2.862-870.2003","volume":"77","author":"M Thomson","year":"2003","unstructured":"Thomson M, Nascimbeni M, Havert MB, Major M, Gonzales S, Alter H, Feinstone SM, Murthy KK, Rehermann B, Liang TJ: The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J Virol 2003, 77: 862-870. 10.1128\/JVI.77.2.862-870.2003","journal-title":"J Virol"},{"issue":"Suppl 1","key":"1276_CR95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0168-8278(99)80378-X","volume":"31","author":"JM Pawlotsky","year":"1999","unstructured":"Pawlotsky JM: Diagnostic tests for hepatitis C. J Hepatol 1999,31(Suppl 1):71-79. 10.1016\/S0168-8278(99)80378-X","journal-title":"J Hepatol"},{"key":"1276_CR96","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1073\/pnas.91.16.7792","volume":"91","author":"P Farci","year":"1994","unstructured":"Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH: Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994, 91: 7792-7796. 10.1073\/pnas.91.16.7792","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR97","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1073\/pnas.0501275102","volume":"102","author":"JC Meunier","year":"2005","unstructured":"Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, Alter H, Emerson SU, Cosset FL, Purcell RH, Bukh J: Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci USA 2005, 102: 4560-4565. 10.1073\/pnas.0501275102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR98","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001, 194: 1395-1406. 10.1084\/jem.194.10.1395","journal-title":"J Exp Med"},{"key":"1276_CR99","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s001090050062","volume":"74","author":"HM Diepolder","year":"1996","unstructured":"Diepolder HM, Zachoval R, Hoffmann RM, Jung MC, Gerlach T, Pape GR: The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med 1996, 74: 583-588. 10.1007\/s001090050062","journal-title":"J Mol Med"},{"key":"1276_CR100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","volume":"19","author":"LG Guidotti","year":"2001","unstructured":"Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19: 65-91. 10.1146\/annurev.immunol.19.1.65","journal-title":"Annu Rev Immunol"},{"key":"1276_CR101","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1096\/fj.02-0664fje","volume":"17","author":"JG Bode","year":"2003","unstructured":"Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC, Haussinger D: IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. Faseb J 2003, 17: 488-490.","journal-title":"Faseb J"},{"key":"1276_CR102","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1053\/j.gastro.2005.02.006","volume":"128","author":"W Lin","year":"2005","unstructured":"Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RT: Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 2005, 128: 1034-1041. 10.1053\/j.gastro.2005.02.006","journal-title":"Gastroenterology"},{"key":"1276_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20011124","volume":"195","author":"S Crotta","year":"2002","unstructured":"Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, et al.: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002, 195: 35-41. 10.1084\/jem.20011124","journal-title":"J Exp Med"},{"key":"1276_CR104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1084\/jem.20011145","volume":"195","author":"CT Tseng","year":"2002","unstructured":"Tseng CT, Klimpel GR: Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002, 195: 43-49. 10.1084\/jem.20011145","journal-title":"J Exp Med"},{"key":"1276_CR105","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1099\/vir.0.19513-0","volume":"85","author":"T Taguchi","year":"2004","unstructured":"Taguchi T, Nagano-Fujii M, Akutsu M, Kadoya H, Ohgimoto S, Ishido S, Hotta H: Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol 2004, 85: 959-969. 10.1099\/vir.0.19513-0","journal-title":"J Gen Virol"},{"key":"1276_CR106","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/MCB.18.9.5208","volume":"18","author":"M Gale Jr","year":"1998","unstructured":"Gale M Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG: Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 1998, 18: 5208-5218.","journal-title":"Mol Cell Biol"},{"key":"1276_CR107","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1128\/JVI.75.13.6095-6106.2001","volume":"75","author":"SJ Polyak","year":"2001","unstructured":"Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, Gretch DR: Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001, 75: 6095-6106. 10.1128\/JVI.75.13.6095-6106.2001","journal-title":"J Virol"},{"key":"1276_CR108","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/rmv.466","volume":"15","author":"C Gremion","year":"2005","unstructured":"Gremion C, Cerny A: Hepatitis C virus and the immune system: a concise review. Rev Med Virol 2005, 15: 235-268. 10.1002\/rmv.466","journal-title":"Rev Med Virol"},{"key":"1276_CR109","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1172\/JCI119778","volume":"100","author":"KM Chang","year":"1997","unstructured":"Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A, Chisari FV: Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 1997, 100: 2376-2385. 10.1172\/JCI119778","journal-title":"J Clin Invest"},{"key":"1276_CR110","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4049\/jimmunol.163.2.650","volume":"163","author":"L Frasca","year":"1999","unstructured":"Frasca L, Del Porto P, Tuosto L, Marinari B, Scotta C, Carbonari M, Nicosia A, Piccolella E: Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J Immunol 1999, 163: 650-658.","journal-title":"J Immunol"},{"key":"1276_CR111","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1073\/pnas.92.7.2755","volume":"92","author":"A Weiner","year":"1995","unstructured":"Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM: Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995, 92: 2755-2759. 10.1073\/pnas.92.7.2755","journal-title":"Proc Natl Acad Sci USA"},{"key":"1276_CR112","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20040638","volume":"200","author":"D Meyer-Olson","year":"2004","unstructured":"Meyer-Olson D, Shoukry NH, Brady KW, Kim H, Olson DP, Hartman K, Shintani AK, Walker CM, Kalams SA: Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med 2004, 200: 307-319. 10.1084\/jem.20040638","journal-title":"J Exp Med"},{"key":"1276_CR113","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI200420985","volume":"114","author":"U Seifert","year":"2004","unstructured":"Seifert U, Liermann H, Racanelli V, Halenius A, Wiese M, Wedemeyer H, Ruppert T, Rispeter K, Henklein P, Sijts A, et al.: Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 2004, 114: 250-259.","journal-title":"J Clin Invest"},{"key":"1276_CR114","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","volume":"169","author":"H Wedemeyer","year":"2002","unstructured":"Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B: Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002, 169: 3447-3458.","journal-title":"J Immunol"},{"key":"1276_CR115","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/hep.20856","volume":"42","author":"HC Spangenberg","year":"2005","unstructured":"Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizsacker F, Blum HE, Thimme R: Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 2005, 42: 828-837. 10.1002\/hep.20856","journal-title":"Hepatology"},{"key":"1276_CR116","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.289.18.2413","volume":"289","author":"SL Flamm","year":"2003","unstructured":"Flamm SL: Chronic hepatitis C virus infection. Jama 2003, 289: 2413-2417. 10.1001\/jama.289.18.2413","journal-title":"Jama"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-8-161\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T02:17:52Z","timestamp":1712369872000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-161","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,11]]},"article-number":"161"}}